Clinical Trials Directory

Trials / Completed

CompletedNCT02361190

Effects of Fast Acting Testosterone Nasal Spray on Anxiety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
University of Texas at Austin · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The proposed study will test the effects of a fast-acting testosterone nasal spray on the fear reactions of young men to two distinct anxiety challenges (social and nonsocial) using a double-blind randomized experimental design.

Detailed description

Aim 1: Test the hypothesis that men administered testosterone nasal spray will result in lower levels of anxiety (anticipatory and situational) and greater levels of approach behavior in response to two distinct (social and nonsocial) anxiety challenges relative to men administered placebo spray. Aim 2: Test the hypothesis that anxiety challenge type (social versus nonsocial) will moderate the effects of testosterone administration on subjects' responses to challenge. Aim 3: Test the hypothesis that rejection sensitivity - heightened sensitivity to evaluative threat - will moderate the effects of drug condition on response to the two anxiety challenge tests.

Conditions

Interventions

TypeNameDescription
DRUGTestosteroneAdministration of 1ml aqueous nasal spray containing 7mg testosterone propionate
DRUGPlaceboAdministration of 1ml aqueous saline spray

Timeline

Start date
2015-02-01
Primary completion
2016-04-01
Completion
2016-05-01
First posted
2015-02-11
Last updated
2021-04-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02361190. Inclusion in this directory is not an endorsement.